OC
CLLS

Oppenheimer & Co’s Cellectis CLLS Stock Holding History

Oppenheimer & Co’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-133,890
Closed -$355K – 1444
2024
Q1 		$355K Buy
133,890
+747
+0.6% +$2.07K 0.01% 1115
2023
Q4 		$410K Buy
133,143
+11,723
+10% +$27.8K 0.01% 1031
2023
Q3 		$192K Buy
121,420
+3,731
+3% +$7.29K ﹤0.01% 1269
2023
Q2 		$232K Buy
117,689
+1,526
+1% +$2.93K ﹤0.01% 1245
2023
Q1 		$224K Buy
116,163
+41,111
+55% +$103K ﹤0.01% 1225
2022
Q4 		$158K Sell
75,052
-16,911
-18% -$38.3K ﹤0.01% 1255
2022
Q3 		$211K Buy
91,963
+16,330
+22% +$49.5K ﹤0.01% 1212
2022
Q2 		$214K Buy
75,633
+979
+1% +$3.45K ﹤0.01% 1239
2022
Q1 		$339K Buy
+74,654
New +$411K 0.01% 1147
2018
Q4 		– Sell
-27,499
Closed -$776K – 1261
2018
Q3 		$776K Sell
27,499
-2,363
-8% -$67.9K 0.02% 684
2018
Q2 		$845K Buy
+29,862
New +$889K 0.02% 653
2016
Q4 		– Sell
-10,604
Closed -$255K – 1292
2016
Q3 		$255K Sell
10,604
-1,497
-12% -$39.1K 0.01% 1045
2016
Q2 		$322K Sell
12,101
-234
-2% -$6.86K 0.01% 943
2016
Q1 		$339K Sell
12,335
-1,462
-11% -$35.2K 0.01% 889
2015
Q4 		$428K Buy
13,797
+1,080
+8% +$32.8K 0.01% 823
2015
Q3 		$335K Buy
12,717
+7,081
+126% +$237K 0.01% 954
2015
Q2 		$203K Buy
+5,636
New +$198K 0.01% 1293

Other funds holding CLLS

LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Oppenheimer & Co's CLLS Position: Q2 2024 in Review

Oppenheimer & Co sold out of Cellectis (CLLS) in Q2 2024, closing a stake of 133,890 shares — an estimated $355K sold.

Oppenheimer & Co first reported a position in CLLS in Q2 2015 and held it in 17 quarters. The position peaked at $845K in Q2 2018. 27 funds tracked by Wall St. Rank hold CLLS as of Q2 2024.

  • Oppenheimer & Co reported no remaining Cellectis position as of Q2 2024 after selling out during the quarter.
  • Oppenheimer & Co sold 133,890 Cellectis shares in Q2 2024, an estimated $355K.
  • Oppenheimer & Co first reported a position in Cellectis in Q2 2015 and held it in 17 quarters.
  • Oppenheimer & Co's Cellectis position peaked at $845K in Q2 2018.
  • 27 funds tracked by Wall St. Rank held Cellectis as of Q2 2024.

Based on Oppenheimer & Co's 13F filing for Q2 2024, filed 8 Aug 2024.